According to HIMSS Market Insights research, 93% of respondents agree that access to quality data, across all platforms and workflows, is critical to an organization’s performance. As a result, many of the respondents’ healthcare organizations have integrated or plan to integrate various…
Source: Healthcareitnews.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
